CTRI/2024/01/062071
Not yet recruiting
未知
Burden of financial toxicity in Breast Cancer patients treated with curative intend: a multi-nationalstudy from low-middle income countries (FIT Study). - FIT
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Tata Memorial Centre
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •a. Pathologically confirmed new invasive breast cancer cases
- •b. Invasive breast cancer (AJCC 8th edition)
- •c. Received multi\-modality treatment with curative intent.
- •d. Patient willing to provide all estimates of expenditure before and after coming to
- •the tertiary hospital, share relevant socio\-demographic information and fill or respond to QOL instruments.
Exclusion Criteria
- •a. Unable or unwilling to give written informed consent
- •b. Recurrent or metastatic disease.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Financial Toxicity in Breast Cancer SurgeryBreast CancerNCT05104632McMaster University630
Active, not recruiting
Not Applicable
Study of expenditure on breast cancer treatment in women undergoing treatment at tertiary cancer centerHealth Condition 1: C509- Malignant neoplasm of breast of unspecified siteCTRI/2019/07/020142Womens cancer initiative
Completed
Not Applicable
Investigation on financial toxicity among cancer patients receiving chemotherapyJPRN-UMIN000025043Aichi Cancer Center Hospital156
Completed
Not Applicable
Financial impact of cancer diseases and the resulting psychosocial burden. A qualitative study from the patient´s point of viewC18C34C50C61Malignant neoplasm of colonMalignant neoplasm of bronchus and lungMalignant neoplasm of breastMalignant neoplasm of prostateDRKS00011589Institut für Medizinische SoziologieMedizinische FakultätMartin-Luther-Universität Halle-Wittenberg39
Completed
Not Applicable
Financial Toxicity in Cancer Patients Treated with Radiotherapy – a jDEGRO Confirmatory Cross-Sectional StudyC80.9Malignant neoplasm, primary site unspecifiedDRKS00028784niversitätsklinikum Schleswig-Holstein Campus Kiel1,075